Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-22-000039
Filing Date
2022-04-05
Accepted
2022-04-05 16:05:01
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 20349
  Complete submission text file 0001735276-22-000039.txt   21861
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELI LITTY & CO LIIY CORPORATE CENTER DC 1093 INDIANAPOLIS IN 46285
Business Address
PAUL STEVEN M (Reporting) CIK: 0001237564 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 22806752